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Chronic pancreatitis (CP) is a progressive infl ammatory 
process, which usually evolves over years into pancre-
atic cirrhosis, irrespective of endoscopic or surgical in-
terventions, except autoimmune pancreatitis (reversed 
by steroids) or obstructive pancreatitis (relieved by re-
moval of obstruction). The latter two conditions are not 
considered here, particularly because the typical pro-
gressive evolution of CP is lacking.
In the diagnosis of CP two major problems need spe-
cial attention: (1) staging, that is, differentiation be-
tween early- versus late-stage CP and (2) etiology, 
specifi cally the impact of etiology on the evolution of 
CP from disease onset . Our presentation is focused 
primarily on these aspects and is based in particular on 
data from our prospective long-term study.
Staging of CP
CP evolves over years and is diagnosed reliably in ad-
vanced stages in accordance with the diagnostic hall-
marks: pancreatic calcifi cation, marked ductal alterations 
(Cambridge criteria), and irreversible exocrine (endo-
crine) insuffi ciency. Diagnosis of late-stage CP is identi-
cal for both alcoholic and nonalcoholic CP.
Diagnostic challenge of early-stage CP
The diagnosis of early-stage CP—in contrast to ad-
vanced late-stage CP—is problematic (Fig. 1). Three 
major variables are important markers of the disease 
course from onset to late-stage CP: clinical features, 
morphology, and function. Clinical features and func-
tion are closely interrelated variables and change in as-
sociation with progressive acinar destruction and fi brosis 
from disease onset to late-stage CP.
Early-stage CP usually starts with recurrent acute 
pancreatitis. The diagnostic criteria of acute pancreati-
tis are well established. The broad overlap of clinical 
features in acute pancreatitis irrespective of etiology, in 
particular between gallstone and alcoholic pancreatitis, 
the two most prominent causes of acute pancreatitis in 
industrialized countries (60%–80%), renders a precise 
differentiation between acute and chronic pancreatitis 
virtually impossible at onset. Many experts, therefore, 
prefer to label initial episodes of acute pancreatitis ac-
cording to etiology, for example, as alcoholic or gall-
stone pancreatitis.
Alcohol abuse is a prominent risk factor for both 
acute and chronic pancreatitis. The debate on classifi ca-
tion of CP has been confounded during the past 40 years 
by the dogma of Marseille, which postulates that (1) 
acute pancreatitis and CP are two distinct nosological 
entities and (2) acute pancreatitis virtually never pro-
gresses to CP. In fact, gallstone pancreatitis rarely pro-
gresses to CP.1
In contrast, most experts currently agree that 
alcoholic and hereditary CP are the end result of 
repeated episodes of acute pancreatitis, that is, the 
necrosis–fi brosis hypothesis of CP by Klöppel and 
Maillet.2
Basically, there are three major challenges in the 
diagnosis of early-stage CP: (1) pancreatic histology, 
which is the gold standard of early-stage CP, is rarely 
available; (2) clinical, functional, and morphological 
features are identical at onset in both acute reversible 
(e.g., gallstone) and progressive (alcoholic) pancreatitis; 
and (3) a time lag, averaging 4.5–5.5 years, exists be-
tween acute onset pancreatitis and documentation of 
markers of advanced alcoholic CP.3–5
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Time lag between acute onset pancreatitis and defi nite 
(advanced) CP
Monitoring of pancreatic function is important for dif-
ferentiating acute reversible and chronic progressive 
pancreatitis in the early stages of disease if pancreatic 
histology is not available. For instance, the fecal chymo-
trypsin profi le over a period of more than 10 years from 
disease onset is documented in a series of acute (gall-
stone) pancreatitis attacks (n = 74) versus alcoholic CP 
(n = 114) (Fig. 2). Obviously, the fecal chymotrypsin 
profi le remained normal (>120 µg/g) in acute pancreati-
tis for >10 years. In contrast, the fecal chymotrypsin 
profi le became progressively pathological in CP. How-
ever, the fi rst defi nitely low values occurred 3 years after 
onset. In other words, there was a typical time lag—a 
diagnostic “black-box” period—between disease onset 
and the development of markers of advanced late-stage 
CP.3–5
Thus, a defi nite categorization of pancreatitis in its 
initial stages is often impossible because of this time lag. 
The following case reports illustrate the problem in a 
few patients with acute onset pancreatitis.
Case 1. 60-year-old woman
This patient had biliary acute pancreatitis combined 
with obstructive cholestasis due to choledocholithiasis. 
She initially showed mild pancreatic insuffi ciency, as 
proven by a pathological pancreozymin-secretin test 
(P/S-Test) and low fecal chymotrypsin values (FCT) 
over an 8-month period after disease onset (Fig. 3). 
Some experts would probably conclude that the patient 
has CP. However, the patient was followed-up for 21 
months. At 10 months, a second P/S-Test was normal, 
and the FCT profi le normalized by 21 months after 
disease onset. Thus, the fi nal interpretation of case 1 
was acute biliary pancreatitis with transient (reversible) 
pancreatic insuffi ciency.
Case 2. 41-year-old man
The patient had a fi rst severe episode of acute alcoholic 
pancreatitis in 1974. In 1975, a second mild attack fol-
lowed. Thereafter, the patient remained asymptomatic 
despite continuation of alcohol consumption in moder-
ate amounts. Yearly control studies documented no 
evidence of exocrine insuffi ciency for 12 years after 
disease onset, with constantly high-normal FCT values 
Fig. 1. Scheme of the long-term 
evolution of the three major, closely 
interrelated variables that change in 
association with progressive acinar 
atrophy/fi brosis after onset of chronic 
pancreatitis (CP). For instance, acute 
pancreatitis is the prominent clinical 
feature of the early-stage disease, 
while the markers of late-stage CP 
(persistent exocrine insuffi ciency, 
diabetes, calcifi cation) develop after 
a delay of several years (time lag). 
The diagnostic gold standard of 
early-stage CP is pancreatic histology 
(rarely available). Acute-onset pan-
creatitis and the signs of late-stage CP 
are the two cornerstones of CP in the 
absence of histology. CP can be sus-
pected in cases of recurrent alcoholic 
pancreatitis (probable CP). Defi nite 
CP is, however, best proven (or ex-
cluded) by documentation of signs of 
late-stage CP (see Figs. 3–5). P/S, 
pancreozymin-secretin; GTT, glucose 
tolerance test; ERCP, end oscopic ret-
rograde cholangiopancreatography
1
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Fig. 2. Fecal chymotrypsin profi le 
over a period of more than 10 years 
from onset of acute gallstone (n = 74) 
versus chronic alcoholic pancreatitis 
(n = 114) (Mean ± SEM). In alcoholic 
CP, the fecal chymotrypsin values 
progressively drop, but they become 
abnormal (<120 µg/g) only after a 
time lag of 3–4 years after disease 
onset. (Note that the fecal elastase I 
test was not available before 1995)
Fig. 3. Case 1. This female patient devel-
oped exocrine insuffi ciency following 
acute gallstone pancreatitis (fecal chymo-
trypsin concentration <120 µg/g; P/S-Test) 
that lasted 8 months from onset, suggest-
ing chronic pancreatitis. However, the P/S 
test results were normal at 10 months, and 
the fecal chymotrypsin level was normal 
at 21 months after disease onset, indicat-
ing that the exocrine insuffi ciency was 
reversible and that progression to CP is 
unlikely in this patient
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(Fig. 4). Some experts would probably exclude CP in 
this patient. However, 13 years after onset, the FCT 
values suddenly dropped to very low levels and calcifi -
cation was documented for the fi rst time. Thus, the fi nal 
interpretation in case 2 was alcoholic CP, diagnosed 
after a time lag of 13 years after disease onset.
Case 3. 34-year-old man
This alcoholic patient had four episodes of acute pancre-
atitis within 1 year from onset. The FCT profi le normal-
ized at 1.5 years after onset and remained normal until 8 
years after onset, probably owing to cessation of alcohol 
Fig. 4. Case 2. Long-term disease 
evolution in a patient with severe 
acute alcoholic pancreatitis in 1974, 
followed by a second mild pancreati-
tis attack in 1975. Thereafter, the pa-
tient remained asymptomatic despite 
continued reduced alcohol intake 
(i.e., the pain probably stopped be-
cause of the alcohol reduction). No 
evidence of exocrine insuffi ciency 
was found at yearly control studies 
for 12 years after onset. After this 
time lag, the fecal chymotrypsin val-
ues suddenly dropped, calcifi cation 
was noted, and diabetes (controlled 
by oral antidiabetics) developed at 
20 years after onset
Fig. 5. Case 3. Long-term disease 
evolution following four episodes of 
acute alcoholic pancreatitis within 1 
year. Exocrine insuffi ciency ( path) 
was documented by the fi rst P/S-Test 
(PST), and low fecal chymotrypsin 
values reverted to normal 1.5 years 
after onset, probably due to cessation 
of alcohol intake. At 7 years after 
onset, pancreatitis recurred, and per-
sistent exocrine insuffi ciency devel-
oped following a time lag of 8 years 
after onset, in association with pan-
creatic calcifi cation (Calcif.) at 10 
years after onset. Despite continued 
alcohol abuse, no further episodes of 
pancreatitis occurred in the last 4 
years of life (burn-out of late-stage 
CP; see text below). D-Op, Drainage 
operation
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abuse (Fig. 5). Some experts would probably conclude 
that progression to CP is unlikely in this patient. How-
ever, between 7 and 8 years after onset, pancreatitis re-
curred: a pancreatic pseudocyst developed, which was 
treated by a surgical drainage procedure. Exocrine in-
suffi ciency developed at 8 years after onset (low FCT, 
pathological P/S-Test). Calcifi cation was documented at 
10 years after onset. Thus, the fi nal interpretation in case 
3 was alcoholic chronic pancreatitis, fi rst documented 
after a time lag of 9 years after onset of disease.
Preliminary conclusions
1.  In patients with fi rst onset pancreatitis, categoriza-
tion as acute versus chronic pancreatitis is rarely pos-
sible without histology.
2.  Prolonged surveillance of patients is necessary to 
prove or exclude CP because of the delay in develop-
ment of markers of CP (time lag).
3.  It is likely that a large percentage of patients classi-
fi ed as having acute alcoholic pancreatitis will prog-
ress to CP if followed up for years.
Rate of progression of CP
The rate of progression to alcoholic late-stage CP from 
disease onset varies considerably (Table 1), but the rea-
sons for this variable rate are unknown. There is, how-
ever, evidence that cessation or a reduction of alcohol 
abuse may delay the progression to advanced CP.8 More-
over, smoking appears to accelerate the progression to 
calcifi cation, as shown by a recent international multi-
center study9 (Fig. 6). Etiology is an additional factor 
that impacts the progression rate of CP (see below).
There are only limited data on the relationship be-
tween morphology and function in the course of the dis-
ease from onset to late-stage CP. Our group studied this 
Table 1. Rate of progression to and incidence of late-stage alcoholic chronic 
pancreatitis
 Mayo Clinica Zurich series
 (n = 249)6 (n = 265)7
Calcifi cation
 Incidence (%) 59 86
 Median time after onset (years) (range)  8.7  6 (0–18)
Exocrine insuffi ciency
 Incidence (%) 48 96
 Median time after onset (years) (range) 13.1  5 (1–25)
Diabetes
 Incidence (%) 38 66
 Median time after onset (years) (range) 19.8  8 (1–25)
a The two studies are not strictly comparable mainly because the Mayo series6 was performed in 
part retrospectively
Fig. 6. Rate of progression to pancreatic calcifi cation is signifi cantly increased by smoking in alcoholic CP9
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issue in 73 alcoholic CP patients using either surgical or 
necropsy specimens. Surgical and necropsy specimens 
were available in 10 of 73 patients (Figs. 7 and 8).10
The median fi brosis score (FS, on a scale of 0–12) in-
creased from 6.2 within 4 years of onset to 10.2 at ≥13 
years after onset. Calcifi cation (%) increased almost 
threefold between onset and ≥13 years after onset, 
closely matching the increase in fi brosis (Fig. 7).
Exocrine insuffi ciency (fecal chymotrypsin <120 mg/
g) was closely correlated with the fi brosis score and was 
noted in 87%–97% of patients with a fi brosis score of 7 
to 12 (Fig. 8). Diabetes was observed in about 60% of 
patients with a fi brosis score of ≥10 but in only about 
15% of those with a fi brosis score of ≤9.
These fi ndings indicate that repeated function 
testing is a rather reliable surrogate for histology for 
monitoring the progression of CP. Moreover, the data 
support the notion that advanced late-stage CP can 
be diagnosed reliably by most available routine 
methods if adequate histological specimens are not 
available.
By applying strict criteria, a diagnosis of CP has been 
confi rmed at our center over the last 40 years in a total 
of 343 patients.7 At the same time, an equal number of 
patients (n = 385) with suspected but unproven CP (so-
called probable CP) were excluded because histology 
or data indicating progression to late-stage CP were 
lacking.
Impact of etiology on the rate of progression of CP
Knowledge of the natural history of CP, which is the 
backbone of CP diagnosis, is still limited. For instance, 
only a few previous prospective studies have investi-
gated the long-term evolution of alcoholic versus non-
alcoholic CP separately.7 At present, the assumption 
prevails that the natural history of CP is identical irre-
spective of etiology.11
Diagnosis of advanced CP may be delayed by many 
years in patients with slow CP progression, as shown 
above. Interestingly, the progression rate is particularly 
delayed in patients with nonalcoholic CP, as shown by 
our group7 and by a Mayo Clinic series.6
Idiopathic juvenile “early onset” CP (IJCP), idio-
pathic senile “late onset” CP (ISCP), and hereditary CP 
(HP) are three major distinct nosological entities of 
nonalcoholic CP that differ with respect to age at onset, 
clinical features6,7,9,10 (Table 2), and presence of gene 
mutation.12,13 The fi nal pathway of alcoholic and nonal-
coholic CP is almost identical at late stages, as docu-
mented by the high incidence of calcifi cation and 
exocrine insuffi ciency (Table 2).
Etiology has a major impact on the progression 
rate of CP. In particular, early-stage CP lasts signifi -
cantly longer in IJCP and HP than in alcoholic 
CP (ACP).7 The development of exocrine insuffi ciency 
after disease onset is signifi cantly delayed in IJCP 
and HP versus ACP (Fig. 9). Documentation of calci-
fi cation is also markedly delayed after disease onset 
in HP and IJCP versus ACP (without reaching signifi -
cance) (Fig. 10). In ISCP, constituting a large propor-
tion of primary painless CP (i.e., unknown onset), 
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Fig. 7. Correlation of the fi brosis score (FS; histology score 
0–12) in relation to duration of CP in a series of 73 consecutive 
patients with alcoholic CP. Large pancreas specimens (biopsy 
or autopsy specimens, at different time intervals after onset), 
were assessed by two ex perienced pathologists according to 
the scoring system. The median FS almost doubled from 
6.2 (at 4 years after onset) to 10.2 (at ≥13 years after onset). 
Calcifi cation increased about threefold, in close relation with 
the FS (modifi ed data from reference 10)
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Fig. 8. Relationship between the fi brosis score and pancreatic 
dysfunction (see Fig. 7). Exocrine insuffi ciency was noted in 
87% –97% of patients with a fi brosis score of 7–12. Diabetes 
was noted in about 60% of patients with a fi brosis score of 
≥10 but in only 13% of those with a fi brosis score of ≤9 (modi-
fi ed data from reference 10)
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pancreatic insuffi ciency or pancreatic calcifi cation 
were present in up to 70% of patients at the time 
of diagnosis of CP. The development of diabetes 
differed also signifi cantly in HP and IJCP compared 
with ACP (Fig. 11). In ISCP, diabetes was present 
in 50% of patients with primary painless CP at 
diagnosis.
Obviously, our series is small and additional prospec-
tive long-term studies of mixed medical–surgical CP 
series are required to corroborate our fi ndings on the 
impact of etiology on the long-term evolution of CP. On 
the other hand, our data are in agreement with the re-
sults of the Mayo Clinic series (except for HP, which 
was not considered in that series)6 and with data of a 
large European multicenter study of HP.14
Of special interest in this regard is the debated 
issue of the relationship between exocrine insuffi ciency 
and the pain profi le in CP.7,15 According to the ex-
perience of our group and others,7,16,17 lasting pain relief 
occurs in uncomplicated late-stage CP in association 
with progressive exocrine insuffi ciency—burn-out of 
CP—both in alcoholic and nonalcoholic CP. Because 
of the delay in the progression, the precalcifi c painful 
early stage lasts considerably longer in IJCP and 
HP than in ACP.7 This observation emphasizes the im-
portance of staging CP, which depends largely on func-
tion testing, a currently often-dismissed issue in CP 
diagnosis and therapy.15–18 This controversy, which has 
yet to be settled, is beyond the scope of the present 
review.
Table 2. Clinical characteristics of alcoholic versus nonalcoholic CP (idiopathic 
juvenile, idiopathic senile, and hereditary CP)
 ACP IJCP ISCP HP
 (n = 265) (n = 21) (n = 46) (n = 11)
Male (%) 90  71 87  46
Age at onset (median, years) 36  23 62  10
Follow-up after onset (median, years) 16  22 14  36
With pain (%) 95 100 48  91
Surgery for pain (%) 57  62 27  20
Late stage CP documented by:
 Calcifi cation (%) 86  86 80  91
 Exocrine insuffi ciency (%) 96  86 91 100
 Diabetes (%) 66  33 41  73
Summary of a personal series7
CP, chronic pancreatitis; ACP, alcoholic chronic pancreatitis; IJCP, idiopathic juvenile chronic 
pancreatitis; ISCP, idiopathic senile chronic pancreatitis; HP, hereditary chronic pancreatitis
Fig. 9. The cumulative rate of exocrine 
insuffi ciency is signifi cantly delayed after 
onset in nonalcoholic CP, that is, heredi-
tary (HP) and idiopathic juvenile (IJCP) 
CP, compared with alcoholic CP (ACP) 
(Kaplan-Meier method). In idiopathic 
senile CP (ISCP) without pain (about 
50% of patients with ISCP), exocrine in-
suffi ciency was observed at onset/diagno-
sis in 70% of cases (modifi ed data from 
reference 7)
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Conclusions
1.  CP is a dynamic long-term evolving process, which 
may be divided chronologically into two stages: 
early-stage and late-stage CP.
2.  Late-stage CP can be diagnosed reliably by the mark-
ers of CP: calcifi cation, marked ductal changes, and 
progressive exocrine (endocrine) insuffi ciency. The 
diagnostic criteria are identical for both alcoholic 
and nonalcoholic late-stage CP.
3.  Clinically, early-stage CP is characterized by recur-
rent acute pancreatitis, except in primary painless 
CP—a condition rare in alcoholic but frequent in 
nonalcoholic CP, particularly ISCP (50%).
4.  The diagnostic gold standard of early-stage CP is 
histology (rarely available).
5.  Acute gallstone pancreatitis, in contrast to ACP, 
usually does not progress to CP.
6.  A time lag, averaging 4.5–5.5 years, occurs between 
acute onset alcoholic pancreatitis and documenta-
tion of late-stage CP.
7.  The rate of progression from early- to late-stage CP 
varies considerably for several not clearly defi ned 
reasons, perhaps in relation to continued alcohol 
abuse and smoking.
8.  Etiology has a major impact on the progression rate 
of CP; i.e. marked delay in development of exocrine 
insuffi ciency and calcifi cation after disease onset in 
Fig. 10. Probability of remaining free of 
calcifi cation after onset (see Fig. 9). Cal-
cifi cation developed with a marked delay 
after onset in HP and IJCP compared 
with ACP; the 50% calcifi cation rate in 
ACP/ISCP was 3 to 7 years after onset 
compared with 11 to 14 years in HP/IJCP 
(no statistical difference) (modifi ed data 
from reference 7)
Fig. 11. Probability of remaining free 
of diabetes from onset (see Fig. 9). 
Differences were statistically signifi cant 
between HP/IJCP and ACP/ISCP. In pri-
mary painless ISCP, 12 patients (50%) 
had diabetes at onset/diagnosis (modifi ed 
data from reference 7)
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HP and IJCP compared to ACP. Therefore, diagno-
sis of CP may be markedly delayed in nonalcoholic 
compared with alcoholic CP.
9.  A precise defi nition of etiologically different types 
(i.e., classifi cation) and of different stages of pancre-
atitis (i.e., staging) is necessary for an improved un-
derstanding among experts. At present, terms such 
as acute and chronic pancreatitis are used with dif-
ferent meanings by different authors.
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